Piper Sandler Sees 5 Reasons Aligos Therapeutics Inc. (ALGS) HBV Pipeline Remains Best in Class

Go back to Piper Sandler Sees 5 Reasons Aligos Therapeutics Inc. (ALGS) HBV Pipeline Remains Best in Class
(NASDAQ: ALGS) Delayed: 6.89 +0.12 (1.77%)
Previous Close $6.77    52 Week High
Open $6.77    52 Week Low
Day High $6.97    P/E N/A 
Day Low $6.58    EPS
Volume 67,000